DEA - DUANE BOISE MMJ MARIJUANA RESEARCH DELAYS UNEXPLAINED AS MS AND HD PATIENTS CONTINUE TO SUFFER
- 2 years ago
The DEA has stated, " the DEA anticipates that additional strains of marihuana will be produced and made available to researchers. This should facilitate research, advance scientific understanding about the effects of marihuana, and potentially aid in the development of safe and effective drug products that may be approved for marketing by the Food and Drug Administration,"
Recently the U.S. House of Representatives passed a revised bipartisan bill that would make it easier for researchers to study marijuana. The bill passed Tuesday by a resounding vote of 325-95. The Medical Marijuana and Cannabidiol Research Act, or H.R. 8454, and now goes to the Senate, where it is expected to pass.
Both bills eliminate researchers from obtaining any marijuana products from any state dispensaries or growers.
Researchers can only obtain product for research from DEA approved schedule 1 registrants.
Recently the U.S. House of Representatives passed a revised bipartisan bill that would make it easier for researchers to study marijuana. The bill passed Tuesday by a resounding vote of 325-95. The Medical Marijuana and Cannabidiol Research Act, or H.R. 8454, and now goes to the Senate, where it is expected to pass.
Both bills eliminate researchers from obtaining any marijuana products from any state dispensaries or growers.
Researchers can only obtain product for research from DEA approved schedule 1 registrants.